Therapy News and Research

RSS

AIDS advocates tell WHO: Stop harmful single-dose treatment for expectant mothers and infants

As World AIDS Day 2008 approaches, a coalition of hundreds of HIV/AIDS medical care providers and advocates, representing dozens of organizations, today sent a letter to Dr. Margaret Chan, Director General of the World Health Organization (WHO), urging an end to harmful single-dose HIV/AIDS treatment as a recommended treatment for expectant mothers and infants worldwide.

25 Nov 2008

New study on pancreatic cancer survival

Pancreatic cancer is one of the deadliest and most difficult to treat cancers. Now, in a major step forward, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have shown that administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumors.

25 Nov 2008

Presence of gum disease may help dentists and physicians identify risk of cardiovascular disease

Individuals reporting a history of periodontal disease were more likely to have increased levels of inflammation, a risk factor for heart disease, compared to those who reported no history of periodontal disease, according to an American Journal of Cardiology report available online today.

25 Nov 2008

Understanding how oxidative stress impairs endothelial progenitor cell function may lead to antioxidant therapy to prevent cardiovascular disease

Although its been over a decade since endothelial progenitor cells or EPCs, cells that circulate in the blood repairing and replacing the cells that line blood vessels, were identified, the field is still evolving. EPCs are now being studied as biomarkers to assess the risk of future cardiovascular disease and as potential agents for vascular regeneration.

25 Nov 2008

How to handle the menopause - eat less, get more active and wear HRT skin patches

The latest advice to women going through the menopause is eat less, get more active and consider wearing hormone replacement therapy (HRT) skin patches.

25 Nov 2008

Weight gain during menopause

Weight and appetite experts from around the world met at a conference in Bangkok earlier this year to discuss sex differences in obesity.

24 Nov 2008

New voice care center

UT Southwestern Medical Center has gathered a team of specially trained physicians and therapists to launch a new center for voice care dedicated to disorders of the voice and larynx.

24 Nov 2008

Researchers develop new strategy for broad spectrum anti-viral drugs

Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents.

24 Nov 2008

Double-balloon enteroscopy offers cost-effective approach for obscure GI bleeding

A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding.

24 Nov 2008

Novel device enhances efficacy of standard chemotherapy

NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.

24 Nov 2008

Scientists discover that blocking a neuropeptide receptor decreases nicotine addiction

The study was published in an online Early Edition issue of the Proceedings of the National Academy of Sciences , the week of November 24.

24 Nov 2008

Discovery of novel approach to suppress prostate cancer progression

Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.

24 Nov 2008

Pancreatic duct cells identified as new source of insulin-producing cells

Researchers at the Joslin Diabetes Center have shown that insulin-producing pancreatic beta cells can form after birth or after injury from progenitor cells within the pancreas that were not beta cells, a finding that contradicts a widely-cited earlier study that had concluded this is not possible.

24 Nov 2008

Brookhaven scientists receive patent for improved cancer therapy device

Four physicists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a "medical synchrotron" capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue.

24 Nov 2008

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

Janssen-Cilag announced today that ustekinumab, the first in a new class of biologics, has received a positive opinion for the treatment of moderate to severe plaque psoriasis from the European Committee for Medical Products for Human Use (CHMP).

24 Nov 2008

FDA accepts Labopharm's NDA for formulation of trazodone

Labopharm Inc. has announced that its New Drug Application (NDA) for the Company's novel once-daily formulation of trazodone (DDS-04A), a serotonin antagonist reuptake inhibitor (SARI), for the treatment of major depressive disorder, has been accepted for review and filed by the U.S. Food and Drug Administration (FDA).

24 Nov 2008

New hope for lung disease pulmonary alveolar proteinosis

A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).

24 Nov 2008

New model predicts risk of recurrence in early stage colon cancer patients

Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens.

24 Nov 2008

Risks associated with diabetes drug rosiglitazone may be higher than those with pioglitazone

Older adults who take the diabetes medication rosiglitazone appear to have a higher risk of death and heart failure than those taking the related medication pioglitazone, according to a report in the November 24 issue of Archives of Internal Medicine.

24 Nov 2008

Nplate receives positive opinion for marketing authorisation in Europe

Amgen has announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for Nplate (romiplostim) in the European Union (EU).

21 Nov 2008

Therapy News and Research

AIDS advocates tell WHO: Stop harmful single-dose treatment for expectant mothers and infants

New study on pancreatic cancer survival

Presence of gum disease may help dentists and physicians identify risk of cardiovascular disease

Understanding how oxidative stress impairs endothelial progenitor cell function may lead to antioxidant therapy to prevent cardiovascular disease

How to handle the menopause - eat less, get more active and wear HRT skin patches

Weight gain during menopause

New voice care center

Researchers develop new strategy for broad spectrum anti-viral drugs

Double-balloon enteroscopy offers cost-effective approach for obscure GI bleeding

Novel device enhances efficacy of standard chemotherapy

Scientists discover that blocking a neuropeptide receptor decreases nicotine addiction

Discovery of novel approach to suppress prostate cancer progression

Pancreatic duct cells identified as new source of insulin-producing cells

Brookhaven scientists receive patent for improved cancer therapy device

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

FDA accepts Labopharm's NDA for formulation of trazodone

New hope for lung disease pulmonary alveolar proteinosis

New model predicts risk of recurrence in early stage colon cancer patients

Risks associated with diabetes drug rosiglitazone may be higher than those with pioglitazone

Nplate receives positive opinion for marketing authorisation in Europe

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News